The Vice-Chancellor’s Awards are open for nominations. The awards are a University-wide celebration of outstanding people and their successes across research engagement, innovation, and culture. 👉 Find out more about the award categories at: https://hr.admin.ox.ac.uk/vice-chancellors-awards

Congratulations, Arundhati! 🥳

Parkes lab pre-print alert! ‘TMEM33 deletion potentiates anti-tumor CD8⁺ T cell immunity.’ Led by mtjackson101.bsky.social. Full bluetutorial follows! 1/10 www.biorxiv.org/content/10.6...

Calling all OCION members! The next Oxford Cancer Immuno-Oncology Network/ Oxford Immunology Network targeted immunotherapies-themed seminar will take place on the 27 January at 3PM. Don't miss out! ⬇️

👏👏👏

The Oxford Cancer team are taking a break over the holiday period and will be back in the new year on Monday, 5th January. Please note that inboxes won’t be monitored during this time. Wishing happy holidays to all who celebrate! ☺️

As the year comes to a close, we’re reflecting on some of our 2025 highlights. 🥳 In November, CRUK announced up to £2.06 million in funding to run a clinical trial of LungVax over the next four years. The trial is expected to begin in summer 2026. Read more ⬇️ www.cancer.ox.ac.uk/news/world20...

Submit a late-breaking abstract by January 12 for the AACR Annual Meeting 2026 (April 17-22; San Diego), chaired by Paul S. Mischel and Alice T. Shaw. Learn more: buff.ly/BqvshQ6 #AACR26

As the year comes to a close, we’re reflecting on some of our 2025 highlights. 🥳 In June, we celebrated 2 years of the Oxford Cancer Immuno - Oncology Network (OCION). Read about some of OCION's key achievements on our website. 👇 www.cancer.ox.ac.uk/news/celebra... @timmunologist.bsky.social

We’re reflecting on some of our 2025 highlights. 🥳 The 1st episode of Channel 4's Cancer Detectives: Finding the Cures was broadcast in November. It follows Sarah Blagden, who is leading novel precision prevention cancer research, supported by Oxford Cancer. 🔻

As the year comes to a close, we’re reflecting on some of our 2025 highlights. 🥳 In October, we announced the appointment of the 2025 CRIS Cancer Postdoctoral Clinical Fellows: Drs Rebecca Ling & Casmir Turnquist. Both will lead on research on childhood cancer.

The December edition of Research News is here! Find out about: 🔬 An exciting research project. 💻 A new webinar series. 🩺 UK Prostate Cancer Clinical Research Strategy Group. 💬 Discussion session topic at From Ideas to Innovation. 📚 Read it here: buff.ly/kXTXjdx

New Vacancy: Postdoctoral Researcher in Bioinformatics & Human Tissue Modelling We have an exciting opportunity to join the O'Neill lab, contributing to a pioneering tissue-focused research programme aimed at enhancing cure rates for gastrointestinal cancers. www.oncology.ox.ac.uk/about-us/wor...

Proud to be a member of the Patient Involvement Team on this world class, lifesaving research. Research is where hope starts; research shapes the future; research transforms lives 👇👇

We’re reflecting on some of our 2025 highlights. 🥳 In March, @cancerresearchuk.org committed £5.5M to a research team - co-led by Simon Leedham (@ndm.ox.ac.uk) - tasked with making personalised medicine a reality for people with #BowelCancer. Read more ⬇️ www.cancer.ox.ac.uk/news/ps5m-re...

Congratulations to Kendra Perez-Smith, Translational Support Unit Manager, who has received an Outstanding Contribution to Sustainability Award for her innovation & leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.

As the year comes to a close, we’re reflecting on some of our 2025 highlights. 🥳 Our inaugural OOCCE Symposium took place in February, bringing together collaborators who share a commitment to advancing research into and treatment for oesophagogastric cancer.⬇️ www.cancer.ox.ac.uk/news/oxford-...

New work presented at the San Antonio Breast Cancer Symposium provides some clarity for women with BRCA1 and/or BRCA2 mutations: Menopausal hormone therapy does not increase their risk of breast cancer. Learn more on the #AACRblog: buff.ly/yx1QleK #SABCS25 @sabcs.bsky.social

As the year comes to a close, we’re reflecting on some of our 2025 highlights. 🥳 In January, Oxford University & GSK announced the launch of £50M immuno-prevention programme to advance novel cancer research. The partnership was co-ordinated by Oxford Cancer. 👇 www.cancer.ox.ac.uk/news/oxford-...

Abstract submission is OPEN for the #EACR2026 Annual Congress, and registration opens in the new year 🌍💫 Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts

Researchers at @oncology.ox.ac.uk have developed TrustedMDT, a multi-agent AI system designed to support cancer treatment planning. TrustedMDT is made up of three AI agents that work in concert to summarise clinical records, determine disease stage & draft treatment recommendations. Read more ⬇️

As the year comes to a close, we’re reflecting on some of our 2025 highlights. 🥳 Did you know, in May of this year, we were shortlisted for a @ox.ac.uk Vice Chancellor's Award? Read the full story on our website ⬇️ www.cancer.ox.ac.uk/news/oxford-...

Upcoming webinar: Augmented SBRT & precision in prostate cancer treatment. Hear about current approaches, practical considerations developments within this area. 📅 Jan 28 ⏰ 3:00–4:30 CEST 📍 Zoom Register: bit.ly/492iMjT

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience. 🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

Funding opportunity! 🔊 The Early Detection and Diagnosis Programme Award from @CRUK funds long-term, integrated and potentially renewable programmes of exceptional science to drive change in how early cancers and pre-cancerous states are detected. More 👇 www.cancerresearchuk.org/for-research...

What's most exciting in cancer research right now? We've selected ten remarkable and influential recent papers, offering a concise summary of the cutting-edge advances taking place in the field: magazine.eacr.org/highlights-i...

Time to rethink risk thresholds in #Cancer referral guidelines? A @bjgp.bsky.social editorial, co-written by Brian Nicholson (@oxprimarycare.bsky.social), examines opportunities to refresh how risk thresholds are applied in national primary care referral guidelines. bjgp.org/content/75/7...

Awesome talk from Phil Jones @sangerinstitute.bsky.social on mutant clones in non-malignant tissue Trillions of somatic mutations through lifetime incl skin, gut, bladder, breast, prostate, even neurons & vessels...yet vast majority don't transform #OxCode25 #OxCodeSymp25 @oxfordcancer.bsky.social

And that concludes the #OXCODE25 Symposium! Thanks to all our attendees and speakers - we hope to see you all again next year! #OxfordCancer #EarlyDetection #Prevention

Closing today's #OXCODE25 symposium: our 2nd Keynote speaker, Phil H Jones. Phil will present on 'Pro- and anti- oncogenic mutants in normal epithelia.' #OxfordCancer #EarlyDetection #Prevention

Next up at the #OXCODE25 symposium, Zinaida Dedeic and Maria Aggelakopoulou discuss 'Preventing Lung Cancer with Precision Vaccination: The promise of Lungvax.' You can find out more about LungVax's recent funding from CRUK on our website ⬇️ www.cancer.ox.ac.uk/news/world20...

Opening today's talks around Biology-Informed Prevention at the #OXCODE25 Symposium, Karin Hellner presents 'The future of HPV Cancer Prevention: Advancing Therapeutic Vaccine Strategies'. #OxfordCancer #EarlyDetection #Prevention

Concluding our lightning talks at today's #OXCODE25 symposium: Dimitris Vavoulis presents 'Nanopore Whole-Genome Sequencing of cfDNA for Multi-Cancer Early Detection.' #EarlyDetection #Prevention #OxfordCancer

Ella Mi presents a lightning talk on 'A tri-level cytosine atlas of normal and tumour tissues for early detection of cancer from multimodal cfDNA.' at this afternoon's #OXCODE25 symposium. #OxfordCancer #EarlyDetection #Prevention

Up next: Martijn Kolijn gives a lightning talk on 'Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer Subtypes.' #OXCODE25 #EarlyDetection #Prevention #OxfordCancer

Great discussion - patient groups are central to A/I partnerships -especially in the ED/prevention space….

And to kick off the first of our lightning talks: Tereza Kacerova on 'Integrating NMR Metabolomics and Glycomics for Early Cancer Detection in the SCAN2 Cohort.' #OXCODE25 #OxfordCancer #EarlyDetection #Prevention

Exciting news, cancer researchers - abstract submission is now OPEN for the #EACR2026 Annual Congress! 🌍💫 Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts

Congratulations to Keaton Jones who has received a @wellcometrust.bsky.social Early Career Award 🔬 The funding will enable Keaton & his team to shed light on immunotherapy resistance in pancreatic cancer, a critical hurdle that, if overcome, could provide much needed new treatment options.

Pradeep Virdee begins this afternoon's session on Cancer Risk Stratification at #OXCODE25, discussing 'Test trends for cancer detection in patients presenting with non-specific symptoms in primary care: a diagnostic accuracy, longitudinal cohort study.' #OxfordCancer #EarlyDetection #Prevention

Tim Elliott @timmunologist.bsky.social chairs today's panel discussion at #OXCODE25! The panel consider: 'Are industry/academia partnerships essential for advancing early detection and prevention research for patient benefit?' #OxfordCancer #Prevention #EarlyDetection

And to conclude our talks on Early Detection, Brian Nicholson and Tanvi Rai discuss 'Approaches to inclusion in the AcceleRated Multi-cAncer DIagnostic EvaLuatiOn (ARMADILO) platform.' #OXCODESYMP25 #OxfordCancer #EarlyDetection #Prevention

Great talk from Ros Eeles at #OxCodeSymp25 @oxfordcancer.bsky.social Super summary of #IMPACT_Study & why #NSC recommended #ProstateCancer screening for #BRCA men #EarlyDetection @francoiseshowe.bsky.social @sarahblagden.bsky.social @alexander-colton.bsky.social @leedham-simon.bsky.social

Up next in our Early Detection session, we have Parinaz Mehdipour presenting 'Circular RNA biomarkers for early detection of colorectal serrated lesions.' #OXCODESYMP25 #OxfordCancer #Prevention #EarlyDetection

A slight change to today's programme at #OxCODESYMP25! All Lightning talks will now be taking place in Session 3.

Ros Eeles, our first keynote speaker at today's #OXCODESYMP25, presents 'Genetic predisposition for prostate cancer and opportunities for targeted early detection and prevention'. #OxfordCancer #Prevention #EarlyDetection

Excited to be at the OxCODE symposium, especially as I’m not organising it this year so I can relax and enjoy the science! Delighted that we have Ros Eeles as our 1st keynote speaker on the very topical subject of opportunities for prostate cancer screening #OxCODE25 @oxfordcancer.bsky.social

We're all set up to welcome everyone to today's Oxford Centre for Cancer Early Detection and Prevention (OxCODE) Symposium! #EarlyDetection #CancerPrevention #OxfordCancer #OxCODESYMP25

Are you interested in Patient and Public Involvement (PPI) in research? Julliet Lwiindi, Oxford Cancer's PPI Officer, shares a little about how Cancer Researchers at the University of Oxford can engage with our PPI group 👇 www.cancer.ox.ac.uk/news/blog-pa...

The inaugural AACR #PediatricCancerProgressReport details how research advances have led to over 30 new treatments for pediatric cancers in the last decade, while also highlighting the gaps in care that still exist. Check out highlights from the report on the #AACRBlog: buff.ly/KnmJUIo